Hanmi Pharmaceutical Co., Ltd.
Records under this name other than the patents Hanmi Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Back to Hanmi Pharmaceutical Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,968,316 | Method for the mass production of immunoglobulin Fc region deleted initial methionine residues Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,124,094 | Immunoglobulin Fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,476,230 | Insulinotropic complex using an immunoglobulin fragment Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,263,084 | Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,422,349 | N-Terminal Modified EXENDIN-4 Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,883,402 | Crystalline Forms of a Quinazoline Compound and Its Hydrochloride Salts Formerly held In force · High confidence | In force | High confidence | |
| US 7,737,260 | Protein Complex Using an Immunoglobulin Fragment and Method for the Preparation Thereof Formerly held Term ended Ended no later than Aug 23, 2025 · Medium confidence | Term ended | Ended no later than Aug 23, 2025 | Medium confidence |
| US 8,846,874 | Igg FC Fragment for a Drug Carrier and Method for the Preparation Thereof Formerly held Term ended Term ended Jun 18, 2025 · Medium confidence | Term ended | Term ended Jun 18, 2025 | Medium confidence |
| US 7,736,653 | Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier Formerly held Term ended Term ended Jun 3, 2025 · From the USPTO record | Term ended | Term ended Jun 3, 2025 | From the USPTO record |
| US 8,029,789 | Method for the Mass Production of Immunoglobulin Constant Region Formerly held Term ended Term ended Nov 13, 2024 · High confidence | Term ended | Term ended Nov 13, 2024 | High confidence |